Publications by authors named "Kean Ho"

Claim this Profile
D
Does dose reduction of afatinib affect treatment outcomes of patients with -mutant metastatic non-small cell lung cancer in real-world clinical practice?
Mau Ern Poh, Chee Shee Chai, Chong Kin Liam, Gwo Fuang Ho, Yong Kek Pang, Lye Mun Tho, Kean Fatt Ho, Choo Khoon Ong, Soon Hin How

Transl Lung Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country.
Mau Ern Poh, Soon Hin How, Gwo Fuang Ho, Yong Kek Pang, Harissa H Hasbullah, Lye Mun Tho, Kean Fatt Ho, Choo Khoon Ong

Cancer Manag Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country.
Soon Hin How, Lye Mun Tho, Chong Kin Liam, Harissa H Hasbullah, Gwo Fuang Ho, Kean Fatt Ho, Choo Khoon Ong

Thorac Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients with Mutant Advanced NSCLC in a Developing Country in Southeast Asia.
Soon Hin How, Chong Kin Liam, Muhammad Adil Zainal Abidin, Harissa H Hasbullah, Lye Mun Tho, Gwo Fuang Ho, Kean Fatt Ho, Choo Khoon Ong

Cancer Manag Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologist-led counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.
Sook-Yee Yoon, Siu Wan Wong, Joanna Lim, Syuhada Ahmad, Shivaani Mariapun, Gwo Fuang Ho, Boom Ping Khoo, Beng Hock Teh, Swee Kiong Kho, Doris S Y Chow, Kean Fatt Ho, Paul Hock Oon Ng, Lye-Mun Tho, Meow-Keong Thong

J Med Genet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
David J Thomson, Kean F Ho, Linda Ashcroft, Kim Denton, Guy Betts, Nicholas J Slevin

Acta Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Closing the global cancer divide--performance of breast cancer care services in a middle income developing country.
Gerard C C Lim, Emran N Aina, Soon K Cheah, Fuad Ismail, Gwo F Ho, Lye M Tho, Kwang J Chong, Kean F Ho

BMC Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Kean Fatt Ho, Tom Marchant, Chris Moore, Gareth Webster, Carl Rowbottom

Int J Radiat Oncol Biol Phys· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy.
Kean Fatt Ho, Damien J J Farnell, Jacqueline A Routledge, Meriel P Burns, Andrew J Sykes

Radiother Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for the treatment of longstanding head and neck hemangioma.
Catriona Mairi Douglas, Kean Ho, Jarrod Homer, Nick Slevin

Otolaryngol Head Neck Surg· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
Kean F Ho, Jack F Fowler, Andrew J Sykes, Beng K Yap, Lip W Lee

Acta Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose intensity comparison between weekly and 3-weekly Cisplatin delivered concurrently with radical radiotherapy for head and neck cancer: a retrospective comparison from New Cross Hospital, Wolverhampton, UK.
Kean F Ho, Ric Swindell, Caroline V Brammer

Acta Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
Gareth J Webster, Carl G Rowbottom, Kean F Ho, Nick J Slevin, Ranald I Mackay

Int J Radiat Oncol Biol Phys· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of cisplatin and fluorouracil alone or with docetaxel in squamous cell carcinoma of the head and neck.
Kean Ho, Nick Slevin

Nat Clin Pract Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis